Ampakines Fight Age-Related Memory Loss
Filed in archive Drugs, Vaccines and Therapeutics on July 28, 2006
Scientists have discovered that drugs known as ampakines, developed in the early 1990s to treat age-related memory impairment and other CNS disorders such as Alzheimer's disease and schizophrenia, continue to be effective in reversing the effects of aging on memory even after the drug itself has left the body. In rat studies, the drug appear to increase the production of a naturally occuring protein called brain-derived neurotrophic factor (BDNF), which is vital for long-term memory formation. Also, ampakine-treated rats showed an increased long-term potentiation (LTP), a process in which the connection between the brain cells is enhanced and memory is encoded.
"This is a significant discovery," said gall, professor of anatomy and neurobiology. "Our results indicate the exciting possibility that ampakines could be used to treat learning and memory loss associated with normal aging."
The results of the study is published in the Journal of Neurophysiology. More on this story from UC Irvine.

Permalink: Ampakines Fight Age-Related Memory Loss
Tags: brain alzheimer biotech memory related memory+loss related+memory fight+related
Vote for Ampakines Fight Age-Related Memory Loss:
|
Rating: 8.00 out of 5 vote(s) cast.
|
Most Popular
Best of
Biotech Hubs and Facilities
Biotech/Science Blogs
Corporate and Industrial News
Diagnostics, Methodologies and Instrumentation
Did you know
Drugs, Vaccines and Therapeutics
Energy, Environment and Ecology
Food and Agriculture
Gene Therapy
Genomics, Proteomics and Bioinformatics
Information About
Meetings and Other Events
Microbiology
Misc
Nanomedicine
Other Biotechnology News
Patents and Intellectual Property Rights
Quick introduction
Stem Cells
